GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Change In Inventory

Curocell (XKRX:372320) Change In Inventory : ₩0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Change In Inventory?

Curocell's change in inventory for the quarter that ended in Jun. 2024 was ₩0.00 Mil. It means Curocell's inventory stayed the same from Dec. 2023 to Jun. 2024 .

Curocell's change in inventory for the fiscal year that ended in Dec. 2023 was ₩0.00 Mil. It means Curocell's inventory stayed the same from Dec. 2022 to Dec. 2023 .

Curocell's Total Inventories for the quarter that ended in Jun. 2024 was ₩0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Curocell Change In Inventory Historical Data

The historical data trend for Curocell's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Change In Inventory Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Change In Inventory
- - - - -

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23 Jun24
Change In Inventory - - - - -

Curocell Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₩0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curocell  (XKRX:372320) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Curocell's Days Inventory for the quarter that ended in is calculated as:

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Curocell's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Curocell's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curocell Change In Inventory Related Terms

Thank you for viewing the detailed overview of Curocell's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell Headlines

No Headlines